kras mutation and glutathion Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex JCI - Suppression of the
JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis Cell Death & Disease Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma Cell Death & Disease Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy
Pay in 4 interest-free payments of $5.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1




